2018
DOI: 10.1007/s13239-018-0345-2
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Interstitial Fluid Flow on Drug-Coated Balloon Delivery in a Patient-Specific Arterial Vessel with Heterogeneous Tissue Composition: A Simulation Study

Abstract: Angioplasty with drug-coated balloons (DCBs) using excipients as drug carriers is emerging as a potentially viable strategy demonstrating clinical efficacy and proposing additional compliance for the treatment of obstructive vascular diseases. An attempt is made to develop an improved computational model where attention has been paid to the effect of interstitial flow, that is, plasma convection and internalization of bound drug. The present model is capable of capturing the phenomena of the transport of free … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 41 publications
1
6
0
Order By: Relevance
“…From the findings on the impact of different tissue composition on drug transport, and in accordance with previous literature on DCB computational modelling [ 15 , 16 , 18 ], marked differences in terms of free and bound concentrations were found between the regions Ω HEAL and Ω CALC . These results reflected the difference in terms of effective drug diffusivity, which was 4 orders of magnitude lower in the diseased region than in the healthy one, and the lower maximum binding sites density [ 21 ].…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…From the findings on the impact of different tissue composition on drug transport, and in accordance with previous literature on DCB computational modelling [ 15 , 16 , 18 ], marked differences in terms of free and bound concentrations were found between the regions Ω HEAL and Ω CALC . These results reflected the difference in terms of effective drug diffusivity, which was 4 orders of magnitude lower in the diseased region than in the healthy one, and the lower maximum binding sites density [ 21 ].…”
Section: Discussionsupporting
confidence: 88%
“…The model developed here is characterized by a wide versatility that, for example, could also allow replacement of the idealized geometry with a patient-specific geometrical model (e.g. reconstructed from clinical images as previously performed on 2D sections [ 16 ]), with the final aim of exploring personalized DCB applications. Furthermore, this 3D setting also enables the integration of structural simulations of DCB application, which may provide realistic values of the pressure gradient across the vessel wall to facilitate the realistic incorporation of interstitial flow.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have investigated the role of the heterogeneous atherosclerotic lesion on the eventual efficacy of the therapy. 66 , 67 , 68 In a 2013 study, computational modeling was performed to explore the pharmacokinetics of zotarolimus as a therapeutic agent instead of paclitaxel, the drug used in almost every other study. 21 Additionally, Kolandaivelu et al presented a supervised machine learning framework, using drug coated balloons as an exemplary scenario (Figure 6 ), to process data generated from coarse meshes to predict results derived from highly‐refined meshes – thereby drastically increasing the efficiency in the computational modeling workflow.…”
Section: Biophysics‐based Design Considerations and Strategiesmentioning
confidence: 99%
“…Numerical studies are typically computationally expensive and make a number of (different) assumptions to enable solutions to be obtained in a reasonable time frame. Drug delivery from the DCB is typically modeled as either a constant concentration for a finite time [11] or a timedependent flux [6][7][8][9][10]. All of the aforementioned numerical models assume that drug is transported through the arterial wall due to diffusion: only two models [8,9] account for advective transport due to the known pressure gradient across the arterial wall.…”
Section: Introductionmentioning
confidence: 99%
“…Drug delivery from the DCB is typically modeled as either a constant concentration for a finite time [11] or a timedependent flux [6][7][8][9][10]. All of the aforementioned numerical models assume that drug is transported through the arterial wall due to diffusion: only two models [8,9] account for advective transport due to the known pressure gradient across the arterial wall. Drug binding is dependent on the physio-chemical properties of the particular drug and is handled in different ways in these models, ranging from linear reversible binding kinetics through to multiple phases of nonlinear reversible binding [12].…”
Section: Introductionmentioning
confidence: 99%